Presentations by Tim Sandle

 

Listed below are the main presentations, at conferences or as webinars, delivered by Tim Sandle.

BOOK TIM FOR A WEBINAR, CONFERENCE PRESENTATION OR TRAINING COURSE

To contact Tim about a presentation, conference or webinar, contact Tim via email.

PRESENTATIONS DELIVERED BY TIM (TIMELINE)

1. 'Bacterial Endotoxin Test: Introducing Methodology' to the Parenteral Society One Day Seminar on LAL Testing, 14th March 2002, Manchester
2. ‘Future Direction of Pyrogen Testing’ to PharMIG AGM, November 2002, Peterborough
3. ‘Monitoring – What, When and How Often?’ to Pharmaceutical Cleanrooms, Cambridge, 18th March 2003
4. ‘Sterility Testing – A Practical Approach’, PharMIG Microbiological Methods Validation Conference, St. Albans, 4th June 2003
5. ‘Risk Assessment in the Pharmaceutical Industry’, AUDITS 13, Brussels, 16th September 2003
6. ‘Current Practices in Sterility Testing’, Institute of Validation Technology Microbiology Event of the Year’, December 2003, Dublin
7. ‘Practical Approaches to Sterility Test Validation’, PharMIG Microbiological Methods Validation Conference, Dublin, 25th March 2004
8. ‘Three Aspects of LAL Testing: Glucans, Depyropgenation and Water System Qualification’, PharMIG Endotoxin Course, Waltham Abbey, 3rd June 2004
9. ‘Microbiological Environmental Monitoring in an Isolator Used for Aseptic Filling or Sterility Testing’, AUDITS 15, Brussels, 21st September 2004
10. ‘Environmental Monitoring Risk Assessment’, Institute of Validation Technology Microbiology Event of the Year’, November 2004, Amsterdam
11. ‘Constructing a Viable Environmental Monitoring Programme Using a Risk Assessment Approach’, Pharmaceutical Cleanrooms 2005, 6th September 2005, Cambridge
12. ‘Hot Topics in Pharmaceutical Microbiology’, two interactive sessions, PharMIG Conference, 23rd November 2005
13. ‘NHS Pay Reform’, National Institute of Biological Standards and Control, South Mims, 18th January 2006
14. Hot Topics in Pharmaceutical Microbiology’, interactive session, PharMIG Irish Conference, Cork, 8th June, 2006
15. Distribution of Microbiological Data’, PharMIG Irish Conference, Cork, 7th June, 2006
16. NHS financial crisis and the Blood Service’, NHS Together, Cambridge, 4th March 2007
17. Managing a Microbiology Laboratory Training Programme’, presenter on laboratory training programmes, 29th March 2007, PharMIG Training Event, Derby
18. ‘Applying Failure Mode and Effects Analysis (FMEA) to a Sterility Testing Isolator: A Case Study’, PharMIG Risk Based Management in Pharmaceutical Microbiology, 27th June 2007
19. ‘Managing a Microbiology Laboratory Training Programme’, presenter on microbiology laboratory training programmes, 27th September 2007, PharMIG Training Event, Dublin
20. ‘Best Practices in Microbiological Quality Control and Documentation’, workshop presenter on good documentation practises, 16th October 2008, Pharmig event, Northampton
21. Best Practices in Microbiological Quality Control and Documentation’, workshop presenter on good quality documentation practises, 1st April 2009, Pharmig event, Cork, Republic of Ireland.
22. ‘Managing a Microbiology Laboratory Training Programme’, presenter on microbiology laboratory training programmes, 10th June 2009, PharMIG Training Event, Dublin
23. ‘How to justify doing less monitoring, sampling and testing, and still pass a regulatory inspection’, Pharmig Annual Conference, Nottingham. Session run twice on 18th and 19th November 2009.
24. ‘Contamination control and pharmaceutical microbiology’, two day course co-hosted with Dr Nigel Halls, run for Nobel Farama, Turkey, 5th & 6th January 2010
25. Best Practices in Microbiology Training, two sessions, Pharmig Annual Conference, Nottingham. Session run twice on 24th and 25th November 2010
26. Regulatory Developments: Key Points for Microbiology, Pharmig Annual Conference, Nottingham. Session run twice on 24th and 25th November 2010
27. Cleanrooms and Air Contamination, VIENNI TRAINING, Prune, India, 6th January 2011
28. ‘The Use of Risk Assessment in the Pharmaceutical Industry – the application if FMEA to a Sterility Testing Isolator: A Case Study’, presented at Pharmaceutical Microbiology Conference (SMi Group), Copthorne Tara Hotel, London, 17th January 2011
29. ‘Approaching Sterility Testing’, Hulst Pharma Test Expo, Cologne, Germany, 9th February 2011
30. 'Developments in Regulatory Requirements', ECA 4th Microbiology Conference, Prague, 4th May 2011
31. 'Environmental Monitoring: sterile / non-sterile', ECA 4th Microbiology Conference, Prague, Czech Republic, 5th May 2011
32. "How to Justify Doing Less Monitoring, Sampling and Testing and Still Pass a Regulatory Inspection", PDA's 6th Annual Global Conference on Pharmaceutical Microbiology, Bethesda, MD, USA, 18th October 2011
33. Regulatory Update for Microbiology in 2011, Pharmig Annual Conference, Nottingham. 16th November 2011.
34. 'A risk based approach to environmental monitoring frequencies', ECA 5th Microbiology Conference, Frankfurt, Germany, 10th May 2012
35. Regulatory Updates: 2012, Pharmig Irish Conference, Cork, Ireland, 14 June 2012
36. USP Chapter 1116: environmental monitoring changes, Pharmig Irish Conference, Cork, Ireland, 14 June 2012
37. ‘Review of Cleanroom Microflora’, NHS Pharmaceutical Quality Assurance Service, Annual Symposium for Technical Services, 25th September 2012, The Ashford International Hotel, Kent, UK
38. 'Fungal contamination of pharmaceutical products', Pharmaceutical and Healthcare Sciences Society (PHSS) Annual Conference, 11th October 2012, Winchester, UK
39. USP Chapter 1116: trends in environmental monitoring, Pharmig Annual Conference, Chipping Norton, UK. 6th November 2012
40. Webinar 'Human Microbiome Project', Microbiology Network (with Tony Cundell and Scott Sutton), 5th March 2013.
41. 'Fungi in pharmaceutical manufacturing', European Compliance Academy Microbiology Conference, Copenhagen, Denmark, 25th April 2013
42. 'USP 1116 and its impact upon pharmaceutical microbiology', Pharmig webinar, 1st May 2013
43. 'The use of control strains for the quality control of culture media', American Pharmaceutical Review Webinar, 14th August 2013 (with Liz Kerrigan of ATCC)
44. 'Hospitals, Water Systems and Contamination, NHS QA Symposium, Chester, UK. 24th September, 2013
45. 'Rapid Microbiology Methods and Risk Assessment in the Pharmaceutical Industry', American Pharmaceutical Review Webinar, 16th October 2013 (with Jackie Horrige, BioVigilant)
46. 'The Human Microbiome Project and Implications for Pharmaceutical Microbiology', PDA 8th Microbiology Conference, Bethesda, MD, USA, 21st October 2013
47. 'Best Microbiological Practices for cleanroom gowns, gloves and masks', Pharmig Annual Conference, 21st November, 2013
48. 'Implications of fungal contamination of pharmaceutical products', Pharmig Annual Conference, 21st November, 2013
49. Best practices in managing microbial excursions and managing out of specification events, webinar for European Pharmaceutical Review, 3rd December 2013
50. Fungi and pharmaceutical manufacturing, webinar for Pharmig, 19th February 2014
51. Fungal contamination of pharmaceuticals products, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, 29th April, 2014
52. Human Microbiome Project, European Compliance Academy, Prague, May 2014
53. Essential Components for Implementation of a Robust Environmental Monitoring Program (with Anne Connors, Merck Millipore), American Pharmaceutical Review, webinar, 9th July 2014
54. Contemporary issues in pharmaceutical microbiology, NHS QA Symposium, Kenilworth, UK, 17th September 2014
55. Media Fill Trials for Aseptic Process Control in Sterile Pharmaceutical Manufacture, webinar for Cleanroom technology (with Colin Booth, ThermoFisher), 24th September 2014
56. Key points for Cleanroom Disinfection, Gerpac 17th Conference, Presqu’ile de Giens, Hyères, France, 2nd October 2014. (DOI: 10.13140/2.1.5029.76)
57. Constructing an environmental monitoring program, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014
58. Risk assessment for environmental monitoring, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014
59. An environmental monitoring workshop, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014 (with Dr. David Roesti).
60. Cleanroom contamination and disinfection, Pharmig Cleanroom seminar, 28th October 2014, Birmingham, UK
61. Implications of the human microbiome for cleanrooms, Pharmig Annual Conference - Key Note Speaker, Nottingham, UK, November 2014
62. Risk Based Environmental Monitoring & Lean Manufacturing, 25th February 2015, Novatek International, Webinar.
63. Best practices for an environmental monitoring programme, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, U.K. April 28, 2015
64. Risk assessment and microbiological risks to pharmaceuticals, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, U.K. April 28, 2015
65. Webinar - Microbiological Risk of Personnel and Cleanrooms - 28th May 2015
66. Webinar - Disinfection/Sanitisation Processes: cGMP for Cleaning and Disinfection, 25th June 2015, Pharmig - 25th June 2015
67. The Problem with Spores in Aseptic Units, presented at 'Sporicides – As Part Of Your Transfer Process' - a Pharmig ./ NHS joint symposium, Birmingham, U.K. on 1st July 2015
68. Sporicidal Products - a problem of definition and control, presented at 'Sporicides – As Part Of Your Transfer Process' - a Pharmig ./ NHS joint symposium, Birmingham, U.K. on 1st July 2015
69. Environmental control and environmental monitoring, presented at King's College Hospital NHS Trust, London, U.K., on 24th July 2015
70. Validation of an Agar Plate Active Microbial Air Sampler According to ISO 14698, Merck webinar, 16th September 2015
71. The future of ISO 14698, Merck webinar, 16th September 2015
72. Microbiology Laboratory Myths, 10th PDA Global Microbiology Conference, Bethesda, MD, USA, 19th October 2015
73. Ask the experts panel, 10th PDA Global Microbiology Conference, Bethesda, MD, USA, 19th October 2015
74. Disinfection Processes for Pharmaceuticals and Surface Sampling on Sanitized Surfaces, Merck webinar, broadcast in Europe and North America (2 sessions) on 22nd October 2015
75. Bioburden control and objectionable organisms (with Andy Martin), Pharmig Microbiology Conference, Nottingham, U.K., 25th November 2015
76. Environmental Monitoring Risk Assessment and the Lean Approach, Pharmig Microbiology Conference, Nottingham, U.K., 26th November 2015
77. Best practices for aseptic operator practice and gowning, Pharmig Microbiology Conference, Nottingham, U.K., 26th November 2015
78. ISO 14644 Revision to Parts 1 and 2 (2015 updates), Pharmig webinar, 4th February 2016
79. Overview of environmental monitoring regulations, Pharmig Environmental Monitoring Course, The Oxfordshire Hotel, Oxford, 3rd March 2016
80. Environmental monitoring incubation strategies, Pharmig Environmental Monitoring Course, The Oxfordshire Hotel, Oxford, 3rd March 2016
81. Bacterial and fungal spores - aseptic processing risks, Pharmig & NHS Sporicidal Meeting, The Oxfordshire Hotel, Oxford, 4th March 2016
82. Selection of disinfectants and sporicides, Pharmig & NHS Sporicidal Meeting, The Oxfordshire Hotel, Oxford, 4th March 2016
83. Environmental monitoring trending for risk mediation and lean manufacturing, PDA Europe, 10th May 2016 - webinar
84. Environmental monitoring and microflora - key points, ECA Pharmaceutical Microbiology Conference, Barcelona, 11th May 2016
85. Investigating Sterility Test Failures, Joint Pharmaceutical Analysis Group, Royal Society for Chemistry, London, 12th May 2016
86. Environmental monitoring incubation strategies, Pharmig Irish Conference, Fota Island Hotel, Cork, 18th May 2016
87. Best practices in pharmaceutical gowning, at: PHSS Sterile Products Manufacture June 9, 2016, Hallmark Hotel Manchester Airpor
88. Best practices for investigating sterility test failures, Pharmig webinar, 6th September 206
89. Depyrogenation Studies, A3P, Lyon, 18th September 2016
90. Best practices with microbiological culture media, Pharmig 24th Conference, Nottingham, UK, 17th November 2016
91. Cleanroom contamination; the Problem Spores and the need for Sporicides, Pharmig conference, Wednesday 15th Feb 2017 - Nailcotte Hall Hotel, Berskwell, Warwickshire
92. Introduction to cleanrooms, Thursday 16th Feb 2017- Nailcotte Hall Hotel, Berskwell, Warwickshire
93. Current regulations for environmental monitoring, Wednesday 24th May 2017, Pharmig conference, Portmarnock Hotel & Golf Links, Co. Dublin, Ireland
94. Selecting culture media for environmental monitoring, Wednesday 24th May 2017, Pharmig conference, Portmarnock Hotel & Golf Links, Co. Dublin, Ireland
95. Approaching depyrogenation, Pharmig webinar, 10th August 2017
96. ‘Fungal Contamination in Pharmaceutical Products and Cleanroom Risk’, webinar for Pharmig, 4th October 201
97. Environmental monitoring - limitations, incubating, and trending, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia
98. Training in cleanroom contamination, disinfection, and cleaning techniques, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia
99. How to manage sterility test issues and failure investigations, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia
100. Quantitative determination of endotoxin, Pharmig open discussion session, Pharmig Annual Conference, Oxfordshire, UK, 30th November 2017
101. Risk Based Approach to Environmental Monitoring, webinar for Compliance Online, 19 December 201
102. Sterility test failure investigations, webinar for Compliance Online, 23 Jan 2018
103. Review of EU GMP Annex 1, webinar for Compliance Online, 15 March 201
104. Introduction to disinfectants for GMP industries, Ecolab webinar, 3 April 2018
105. Fungi and cleanroom contamination, webinar for Compliance Online, 26 April 2018
106. Pharmig review of Annex 1, Pharmig webinar, 3 May 201
107. Bacterial and fungal spore risks to pharmaceutical processing, Webinar, Online Compliance Panel, 23rd May 201
108. Best practices in microbial culture media, Pharmig Irish Conference, Dublin, Ireland, 30th May 2018
109. Insight into EU GMP Annex 1, Pharmig Irish Conference, Dublin, Ireland, 30th May 2018
110. Introduction to FMEA: Risk assessment tool for pharmaceuticals, Pharmig risk assessment course, Dublin, Ireland, 31st May 2018
111. Good Design Practices For Pharmaceutical Water Systems, webinar, Online Compliance, 28th June 2018
112. Developing a meaningful environmental monitoring programme, Pharmig Hot Topics Pharmaceutical Microbiology – India, 17th July, Hilton Bangalore Embassy Golf Links, Bangalore
113. Developing a meaningful environmental monitoring programme, Pharmig Hot Topics Pharmaceutical Microbiology – India, 19th July, Hyatt Hyderabad Hotel, Hyderabad
114. Introducing the human microbiome, Webinar, Online Compliance Panel, 25th July 2018
115. Cleanrooms and contamination control, Webinar, Online Compliance Panel, 30th August 2018
116. Burkholderia cepacia complex: risks to non-pharmaceutical products, Webinar, Online Compliance, 20th September 2018
117. Pharmaceutical microbiology: Current and future challenges, PDA Europe – Key Note Speaker, Berlin, 15th October 2018
118. Global Best Practices for Cleaning and Disinfection of Cleanrooms and Disinfection Validation, Online Compliance Panel, 18th October 2018
119. Cleaning Validation Top Challenges: What you need to know, Novatek International Webinar, 24th October 2018
120. Pharmaceutical Water Systems: Microbiological Control, Pharmig Webinar, 24th October 2018
121. Cleanrooms gown and personal control, 22nd November 2018, Online Compliance Panel
122. Best practices in microbiological culture media, Pharmig Annual Conference, 28th November 2018
123. Best practices in sterilisation by heat, UCL QP Training London, 5th December 2018
124. Best practices for sterilisation by filtration, UCL QP Training London, 5th December 2018
125. Sterility test best practices, UCL QP Training London, 5th December 2018
126. Best practices for microbial identification, webinar, Compliance Online, 14th December, 2018
127. Risk assessment case studies for environmental monitoring, Pharmig Environmental Monitoring Best Practices, Nailcotte Hotel, Birmingham, 13th February 2019
128. Impact of the microbiome on environmental monitoring, Pharmig Environmental Monitoring Best Practices, Nailcotte Hotel, Birmingham, 13th February 2019
129. Problem of bacterial and fungal spores in pharmaceutical facilities, Online Compliance Panel, 21st February 2019
130. Out of Specification Investigations: A New Look at the Topic, 7th March 2019, webinar for Online Compliance Panel
131. Applying FMEA risk assessment to a sterility testing isolator, 21st March 2019, webinar for Online Compliance Panel
132. What to expect from the revised EU GMP Annex 1?., Pharmig Croatia Conference, 27th March 2019, Zagreb
133. Operation of sterility test isolators and validation issues, Pharmig Croatia Conference, 27th March 2109, Zagreb
134. Cleaning and disinfection of cleanrooms – why e-learning matters, Pharmig Croatia Conference, 27th March 2019, Zagreb
135. What to expect from the revised EU GMP Annex 1?., Pharmig Slovenia Conference, 28th March 2019, Ljubljana
136. Operation of sterility test isolators and validation issues, Pharmig Slovenia Conference, 28th March 2019, Ljubljana
137. Cleaning and disinfection of cleanrooms – why e-learning matters, Slovenia Conference, 28th March 2019, Ljubljana
138. Introducing Pharmig’s e-learning platform for cleaning and disinfection of cleanrooms, webinar for Pharmig, 18th April 2019
139. How to justify doing less microbiological sampling and testing, and still pass a regulatory inspection, 25th April 2019, Online Compliance Panel
140. Best practice in environmental monitoring, Assuring the quality of medicines III: aseptic products, Royal Society of Chemistry, London, 9th May 2019
141. Aseptic processing challenges panel, Assuring the quality of medicines III: aseptic products, Royal Society of Chemistry, London, 9th May 2019
142. Microbiological aspects of cleaning validation, Pharmig Irish Conference, Dublin, 15th May 2019
143. Best practices in endotoxin testing open discussion, Pharmig Irish Conference, Dublin, 15th May 2019 (run twice)
144. Three case studies relating to endotoxin contamination in water systems, Pharmig Pharmaceutical water systems, Dublin, 16th May 2019
145. Practical Approaches to Sterility Test Validation: Overcoming difficult products, Online Compliance Panel webinar, 24th May 2019
146. Cleanroom gowning and personnel control, Pharmig webinar, 12th June 2019
147. Handling data integrity in the microbiology laboratory, Online Compliance Panel webinar, 20th June 2019
148. Developing an environmental monitoring programme, Online Compliance Panel webinar, 11th July
149. Developing a contamination control study for pharmaceuticals and healthcare, 1st August 2019, Online Compliance Panel webinar
150. Fungal Contamination and Pharmaceutical Products Recall, 19th September 2019, Online Compliance Panel webinar
151. Supplier Oversight and Quality Control for Patient Safety, Voices In Validation, 4th October 2019
152. Risk assessment and environmental monitoring. At Pharmig’s Best Practices in Microbiological Environmental Monitoring, 15th October 2019 Radisson, Hyderabad, India
153. Risk assessment and environmental monitoring. At Pharmig’s Best Practices in Microbiological Environmental Monitoring, 16th October 2019, Hilton, Mumbai, India
154. Fungal contamination of pharmaceutical products, webinar compliance online, 19th October 2019
155. Environmental monitoring – best practices, Pharmig annual conference, 13th November 2019, Nottingham UK
156. New regulatory standards and updates, Pharmig annual conference, 14th November 2019, Nottingham UK
157. Human microbiome and its implications for cleanrooms, NHS QA and Technical Services Symposium, Bristol, UK, 27th November, 2019 – Key note speaker
158. What to Expect From the New EU GMP Annex 1, Online Compliance Panel webinar, 9th January 2020
159. Risk assessment of aging pharmaceutical facilities, Pharmig webinar, 6th February 2020
160. The lean laboratory and a new approach for environmental monitoring, Online Compliance Panel, 13th February 2020
161. The problem with bacterial and fungal spores for pharmaceutical cleanrooms, Assentpro webinar, 25th February 2020
162. Annex 1 2020 revision – an overview, Voices In Validation, 12th March 2020
163. Three case studies relating to endotoxin contamination in water systems, Pharmig Control of Pharmaceutical Water Systems, Virtual Conference, 31st March 2020
164. EU GMP and the implications for sterile products manufacture, RRSL webinar, 1st April 2020
165. Introducing Annex 1 and updates for sterility assurance, UCL QP webinar, 15th April 2020
166. Microbiological aspects of cleaning validation, Pharmig webinar, 30th April 2020
167. Focal points for the release of sterile products, RSSL webinar, 6th May 2020
168. Round up of new standards and regulations during the past year, Pharmig Spring Conference, 20th May 2020
169. Latest draft of Annex 1 – what do we do next?, Pharmig Spring Conference, 21st May 2020
170. Risk assessment tools for environmental monitoring, Pharmig Best Practices in Environmental Monitoring 27th May 2020
171. Incubation strategies for environmental monitoring, Pharmig Best Practices in Environmental Monitoring, virtual conference, 28th May 2020
172. Investigating sterility test failures, RRSL webinar, 4th June 2020
173. Best practices for cleanroom gowning, Pharmig webinar, 4th June 2020
174. Microbiological Aspects of Cleaning Validation, 5th June 2020, Cleaning Validation and Environmental Monitoring, Volanthen Conferences, Prague.
175. Anatomy of Annex 1, UCL, 2nd July 2020
176. Best practices in environmental monitoring, RSSL webinar, 2nd July 2020
177. Investigating sterility test failures, IPSE India, 4th July 2020
178. Selection and qualification of alternative and rapid microbiological methods, PHarmig rapid methods online workshop, 13th August 2020
179. Great myths of Pharmaceutical Microbiology, Pharmig webinar, 27th August 2020
180. EU GMP Annex 1 Current guidance and the new draft: Implications for sterile pharmaceutical products manufacturing, PDA New England Chapter, 3rd September 2020, Boston, U.S.
181. Blood and Plasma Products, UCL, London, 8th September 2020
182. Cleaning validation for the food industry, Campden Food Research Association, 6th October 2020, online conference
183. Cleanroom design, UCL, London, 6th October 2020 (run multiple times)
184. Environmental monitoring, UCL, London, 6th October 2020 (run multiple times)
185. Disinfection and preservation, UCL, London, 6th October 2020 (run multiple times)
186. COVID19 preventative measures for pharmaceuticals, Pharmig Adriatic Conference, 21st October 2020
187. Best practices with microbiological culture media, Pharmig Adriatic Conference, 22nd October 2020
188. Consideration of COVID-19 Prevention Measures for those working in GMP Pharmaceuticals and Healthcare Facilities, RRSL webinar, 22nd October 2020
189. Microbiological concerns in relation to cleaning validation, IPSE India, 24th October 2020
190. Best practices for cleaning and disinfection of GxP environments, RSSL webinar, 18th November 2020
191. Prerequisites for Testing, including control of culture media and method validation, HPRA training session for GMP inspectors, 19th November 2020 (with Edel Fitzmaurice)
192. Microbial identifications, HPRA training session for GMP inspectors, 19th November 2020 (with Edel Fitzmaurice)
193. Environmental Monitoring, HPRA training session for GMP inspectors, 19th November 2020
194. Sterility Testing, HPRA training session for GMP inspectors, 20th November 2020
195. Biological Indicators, HPRA training session for GMP inspectors, 20th November 2020
196. Case Studies Microbial Deviations /Contamination. HPRA training session for GMP inspectors, 20th November 2020 (with Edel Fitzmaurice)
197. Microbiological concerns with cleaning validation (Validacao de Limpeza), PDA Brazil, São Paulo, 23rd November 2020
198. Hygienic design: Best practices for pharmaceutical facilities, 30th November 2020, Cleaning Validation Conference, Vonlanthen Conferences, Austria
199. Sterility testing: Overcoming difficult products, RSSL webinar, 3rd December 2020
200. More pharmaceutical microbiology myths, Pharmig Annual Conference, 3rd December 2020
201. Brexit and implications for the Qualified Person, UCL, London. 9th January 2021
202. E-cigarettes, vaping products, and microbial contamination, Keeping Learning at BPL, 14th January 2021
203. Veil of compliance? What exactly does a facemask do and why should I wear one?, Keeping Learning at BPL, 8th August 2020
204. Introducing the human microbiome, Keeping Learning at BPL, 9th April, 2020
205. COVID-19: Does it require a new standard?,3rd Annual Cleanroom Design and Engineering Forum, TBM Group, Czech Republic, January 2021
     
206. What’s lurking in the water?, Pharmig webinar, 11th February, 2021
207. Investigating Endotoxin Contamination in Pharmaceutical Water Systems, IPSE webinar, 12th February 2021  
208. EN17141 – what can we learn from the new standard?, PDA New England chapter webinar, 3^rd March 2021
209. Pharmaceutical products recalls, UCL, London, 6^th March 2021
210. Evaluation of Milliflex Quantum for the testing of pharmaceutical water, Merck webinar, Germany,16^th March 2021   
211. The key focal points about EU GMP Annex 1, RSSL, 24th March, 2021 
     
212. Best data integrity practices for microbiology, Pharmig webinar, 1^st April 2021
213. Investigating Burkholderia cepacia, Pharmig webinar, 13^th April 2021
214.  Key points from EU GMP Annex 1, PDA West Coast Chapter, webinar, 15^th April 2021  
215. Anatomy of a Contamination Control Strategy, Ecolab Life Science, Global Audience Broadcast, 26^th April 2021 
216. Quality Risk Management for Pharmaceuticals, RSSL, 27^th April 2021  
217. Validation and investigation of the sterility test, PDA Brazil, 24^th May 2021
218.  Application of environmental isolates, Pharmig, 25^th May 2021
219.  Developing a contamination control strategy, RSSL,26^th May 2021  
220. Risk considerations for the presence of pyrogens and the need for the MAT test in pharmaceutical processing, Merck Pharmaceutical Microbiology international Conference, 16^th (North America) and 17^th (Europe) June 2021, online 
221. Practical solutions to real events: Endotoxin contamination of water systems, Endotoxins: LAL today / LAL tomorrow Pharmig conference, 23^rd June 2021. Online 
222. Best practices for out of specification investigations, Pharmig webinar, 29^th June 2021 
223. Cleanroom design: The key factors, RRSL webinar, 30^th June 2021 
224. Designing a biocontamination control standard, Pharmig webinar, 8^th July 2021
225. Environmental monitoring: Understanding your process. AB Scientific / Sherpa Pharma, 22^nd July 2021 
226.  Protecting products from people in pharmaceutical cleanrooms, 29th July 2021, RSSL 
227.  Sterility testing: Validation and failure investigations, 6^th August 2021, U.S. FDA CBER specially requested training webinar    
228. Factors for success: Rapid microbiological methods, PDA Singapore, 16^th September 2021
229.  Sporicides and spore contamination, Pharmig webinar, 22nd September 2021
230. Spores in my Cleanroom – Remediation and Disinfection Strategies, RSSL webinar, 30th September 2021
231. Endotoxin indicators and Depyrogenation studies, Pharmig, 19th October 2021 
232. Where can autoclaves go wrong and cause biological indicator failures, Pharmig Biological Indocators,19th October 2021
233. Designing a disinfectant field trial, Pharmig, 21st October 2021
234. Control measures for pharmaceutical water systems, RSSL webinar, 27th October 2021 
235. Rapid microbiological methods: opportunities and new challenges for the manufacturers, Pharma Microbiology Congress, Pharma Education Centre 2021, virtual conference, 5th November 2021
236. Review of EN 17141:2020, Pharmig Annual Conference, 17^th November 2021  
237. Sterility Assurance in Cell Therapy Products, 24th November 2021, RSSL  
238. Contamination control – focusing on the human, The Future of QC/QA for Complex Biologics, 
     European Pharmaceutical Review, on 30th November 2021, virtual conference.
239. A vision for your new and improved cleaning validation process, Kenx webinar (with NovaTek), December 2021
     
240. Introduction to Mycoplasma and Cell Product Risks, RRSL webinar, 22nd December 2021
241. Lister Institute: Plague, smallpox and blood, Radlett Probus, Aldenham Golf Club, 16th February 2022
242. Viral control in pharmaceutical manufacturing, Pharmig webinar, 23^rd February 2022
243.  Viral testing strategy for pharmaceuticals, American Pharmaceutical Review webinar, 17^th March 2022 
244.  Application of R3A agar for water microbiology, Merck webinar, 22^nd March 2022 
245.  Ensuring that EM sample site selection and sampling frequencies are properly established, Excellence in cleanroom operations, quality assurance and control, 12^th April 2022, Prague 
246. Risk assessment and environmental monitoring, In-House Virtual Training for Allergy Therapeutics: Best Practice in Environmental Monitoring, 13^th April 2022 
247. Case studies: Where has contamination come from?, In-House Virtual Training for Allergy Therapeutics: Best Practice in Environmental Monitoring, 13^th April 2022 
248. Getting in safely - Contamination transfer, Pharmig webinar, 26^th April 2022
249. Risk based environmental monitoring, In-House Virtual Training for Allergy Therapeutics: Best Practice in Environmental Monitoring, 18^th May 2022
250.  Contamination control in pharma In-House Virtual Training for Allergy Therapeutics: Best Practice in Environmental Monitoring, 18^th May 2022 
251.  Rapid methods for environmental monitoring, European Pharmaceutical Review QC Methods Conference, 18^th May 2022      
252. Contamination control strategies for cleaning and disinfection: A case study (with Helen Gates, Ecolab), Cleanroom Technology Conference, Birmingham, 27^th May 2022  
253. Approaching error risk reduction: Making your labs more compliant, Pharmig Webinar, 1^st June 2022
254. Microbial data deviations and the investigation process, Pharmig Irish Conference, Dublin, 8th June 2022 
255. Designing a disinfectant field trial, Pharmig Cleaning and Disinfection conference, Dublin, 9th June 2022 
256. Transfer disinfection, Ecolab European webinar, 10th June 2022 
257. Residue risks and disinfection, Ecolab USA webinar, 14^th July 2022
258. Overview of blood products and plasma processing, Accord, 12^th October 2022 
259. Designing a Contamination Control Strategy – workshop, RSSL,  13^th October 2022 
260. HACCP for environmental monitoring, Pharmevo, Pakistan, 14^th October 2022  
261. EU GMP Annex 1: A pathway to implementation, RSSL webinar, 9^th November 2022 
262. Contamination control strategy and transfer disinfection #1, Ecolab webinar, 10^th November 2022
263. Contamination control strategy and transfer disinfection #2, Ecolab webinar, 15^th November 2022  
264. Annex 1 and advances in environmental monitoring, Pharmaceutical Microbiology Congress, 23^rd November 2022, online conference  
265. Annex 1 - what the regulators missed, Pharmig Annual Conference, 2nd December 2022 
266.  Contamination Control Strategy – Putting the jigsaw together, RSSL webinar, 18th January 2023
267.  Keeping environmental monitoring relevant: Fine tuning the programme, RSSL, 21st February 2023
268. Clarifying ambiguities of Annex 1 in relation to continuous microbiological monitoring, Monitoraggio microbiologico ed Annex 1, AM Instrument, 28 Febbraio 2023
269. Sterile Products and Sterility Assurance, Dame Alice Owens School, 9th March 2023
270. Pharmaceutical cleaning validation, RSSL, April 2023
271.  Best practices in environmental monitoring (workshop), Pharmig Irish Conference, 17th May 2023, Kilashee, Ireland
272.  What’s lurking in the water: Review of microbial contamination in pharmaceutical water systems, 18th May 2023, Kilashee, Ireland
273.  How water systems can go wrong and what to do about it, RSSL webinar series, 24th May 2023
274. Microbial Investigations, 31^st May 2023, Pharmig  
275. Pharmaceutical water systems and contamination concerns, 20^th June 2023, Pharmig
276.  Design and qualification of pharmaceutical isolators, RSSL webinar series, 21^st June 2023  
277. Participant of the panel ‘Developing a modern contamination control strategy’ as part of the European Pharmaceutical Review ‘The future of Biopharmaceutical Analysis’ virtual summit on 29^th June 2023.  
278. Zap! Novel sterilisation technologies, Pharmig webinar, 3^rd August 2023
279. Advantages of automated microbial colony counting, European Pharmaceutical Review, webinar, 20^th September 2023
280. Developing an environmental monitoring strategy, Novatek Europe, Germany, 31^st October 2023
281. Applying quality risk management to environmental monitoring, Novatek Europe, Germany, 31^st October 2023
282. Cleanroom microbiota: What the information tells us?, Pharmaceutical Microbiology Conference 2023, Milan,14^th November 2023
283. Contamination Control Panel with Miriam Guest, Helen Gates and Frederick Ayres, Pharmig, Nottingham, UK, 28^th November 2023.
284. Culture media incubation strategies with Laurent LeBlanc, Pharmig, Nottingham, UK, 29^th November 2023
285. Rapid vs conventional methods: Where next?, PHSS Sterile Product & Aseptic Processing Conference, The Belfry, Birmingham, 12^th March 2024
286.  Final phase of disinfectant efficacy – the field trial, AM Instruments - PDA Italy Chapter,Managing disinfection within an advanced CCS, Limbiate, Italy, 14^th March 2024
287. Auditing against EU GMP Annex 1 (with Peter Deegan), 26^th March 2024, RSSL, Reading, UK
288. Microbial investigations for non-sterile manufacturing, Pharmig Non-Sterile Pharmaceuticals Conference, 23^rd April 2024, online.
289. Setting the frequencies for microbial environmental monitoring, RSSL webinar, 25^th April 2024
290. Rapid microbiological methods: Planning ‘why’ and ‘how, Pharmig webinar, 30^th April 2024
291. Nine tips for contamination controls success, Dycem webinar, 14^th May 2024
292. Sterility assurance roundtable, Pharmig Irish Conference, 22^nd May 2024
293. Case studies for environmental monitoring, Pharmig Environmental Monitoring Best Practices, 23^rd May 2024
294. Current methods for viral clearance, RSSL webinar, 30^th May 2024
295. Participant at Endotoxin testing: The future of recombinant methods, Future of Bio/Pharmaceutical Analysis Online Summit, European Pharmaceutical Review, 20^th June 2024 with Radhakrishna Tirumalai, Ingo Spreitzer, Phil Duncanson and Allen Burgenson
296. Blood, Plague and Smallpox: 122 of science at Elstree, Kedrion BioPharma Heritage, 5^th July 2024
297.  Microbial identification technologies and developing an ID programme, RSSL webinar, 18^th July 2024
298.  MICROBIOLOGY BEST LABORATORY PRACTICES (A REVIEW OF USP CHAPTER 1117), UNIVERSITY OF PAMPLONA, COLUMBIA, 11TH OCTOBER 2024
299. COOLING DOWN PYROGEN TESTING: LATEST DEVELOPMENTS ON THE REGULATORY LANDSCAPE, PHARMIG HOT TOPICS IN PYROGEN TESTING, VIRTUAL CONFERENCE, 15TH OCTOBER 2024
300. VACCINE, CELL CULTURE AND MYCOPLASMA RISK, RSSL, 22ND OCTOBER 2024
301. ADVANCES IN STERILISATION TECHNOLOGY, PHSS, QP FORUM, WALES, 7TH NOVEMBER 2024